Recombinant Human PTMS Protein，His

PTMS (Post-Translational Modifications) refers to the various biochemical modifications that proteins undergo after their synthesis, significantly influencing their function, stability, localization, and interaction with other molecules. Research into PTMS-proteins has gained considerable traction, driven by the critical role these modifications play in cellular processes and disease mechanisms, including cancer, neurodegenerative disorders, and metabolic diseases. For instance, phosphorylation, ubiquitination, glycosylation, and acetylation are key examples of PTMS, each affecting protein activity and interactions in distinct ways. Over the past few decades, advancements in techniques such as mass spectrometry, cryo-electron microscopy, and label-free proteomics have facilitated the detailed analysis of PTM patterns at the proteome level. These methodologies have unveiled the dynamic nature of PTMS, highlighting their potential as biomarkers for disease diagnosis and therapeutic targets. Consequently, researchers are focusing on developing recombinant proteins that mimic these modifications to study their functional implications and to create novel therapeutic strategies. By elucidating the precise mechanisms through which PTMS affect protein behavior, scientists aim to contribute to a deeper understanding of biological systems and to harness this knowledge for innovative clinical applications. Thus, the investigation of PTMS in recombinant proteins stands at the frontier of molecular biology and biomedical research, offering promising avenues for future discovery and treatment development.